Eli Lilly and Almirall’s Ebglyss (lebrikizumab) has been shown to significantly improve the signs and symptoms of atopic ...

The International Medical Derm Summit 2025 highlighted China's dermatological advancements, fostering global collaboration ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

A recent study found that teens who view cannabis and e-cigarette posts on social media are at risk. The Keck School of ...

Investing.com -- Apogee (NASDAQ: APOG) Therapeutics, Inc. (NASDAQ: APGE) stock surged 24% on Monday after the clinical-stage biotechnology company announced positive 16-week data from its Phase 2 ...

Atopic dermatitis is the most common inflammatory skin disease worldwide but empirical work on monitoring the condition using digital technologies is lacking. This work presents a skin model for ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical innovation is redefining treatment, prevention, and chronic disease care ...

Galderma begins 2 new clinical trials to investigate efficacy and safety of nemolizumab to treat patients with systemic sclerosis: Zug, Switzerland Friday, June 27, 2025, 13:00 Hr ...

Air pollution and temperature extremes were linked to increased atopic dermatitis visits, in a meta-analysis.

This new meta-analysis looked to better solidify connections between atopic dermatitis and environmental irritants, such as climate change and pollution.

The American Academy of Dermatology (AAD) recently issued a focused update to its guidelines on the management of atopic dermatitis (AD) in adults, strongly recommending four recently approved ...

Early childhood atopic dermatitis does not affect executive function during middle childhood, particularly in those with mild phenotypes.